StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PARMCOS-B.BO$35.00+2.76%
Fair $35.00+0.0%

PARMCOS-B.BO

Paramount Cosmetics (India) Limited

Consumer Defensive / Household & Personal ProductsBSE

$35.00

+0.94 (+2.76%)

Fairly Valued+0.0%Fair Value $35.00Fund rank 31/100 · Data gapFallback financials|
SA 39/D
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $14.3M · quality 55.3/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 29/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

39/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 0.2%, below the 5% threshold
Thesis & Journal · PARMCOS-B.BOLocal privado en este navegador · Paramount Cosmetics (India) Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$170M

P/E

318.2x

↑

EV/EBITDA

7.3x

↓

ROE

0.2%

↓

Gross Margin

28.6%

↑

Debt/Equity

0.12

↓
52-Week Range$35
$33$49

TradingView lightweight chart

PARMCOS-B.BO price, volumen y niveles de valoración

Último $35.00Periodo +400.0%
Fair value: $35.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-7.1%

FCF CAGR

+44.5%

FCF margin

50.0%

FCF / Net income

209.09x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $213.9M · net income $512000.0 · FCF $107.1M

2023-FY → 2026-FY

Gross margin

28.6%-23.8% pts

Operating margin

4.9%-2.6% pts

Net margin

0.2%-0.6% pts

FCF margin

50.0%+36.8% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$213.9M$213.9M$203.8M$218.1M$267.2M
Net Income$512000.00$512000.00$300000.00$214000.00$2.1M
EBITDA$26.3M$26.3M$22.1M$24.3M$27.8M
EPS——0.060.040.44
Gross Margin28.6%28.6%35.9%28.8%52.5%
Operating Margin4.9%4.9%2.1%-0.2%7.5%
Net Margin0.2%0.2%0.1%0.1%0.8%
Balance Sheet
Debt/Equity0.120.120.560.600.62
Cash Flow
Free Cash Flow$107.1M$107.1M$14.3M$-2.5M$35.5M
Returns
ROE0.2%0.2%0.1%0.1%1.0%
Valuation
P/E318.18318.18678.501010.0076.61
EV/EBITDA7.287.2814.2913.0410.31
P/B0.830.831.000.970.81
Growth & Yield
Revenue Growth5.0%5.0%-6.5%-18.4%—
EPS Growth——50.0%-90.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -12.3%

Total return

-12.3%

Start / end P/E

n/dx → n/dx

EPS bridge

0.06 → n/d

Residual

-12.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-12.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.